These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26689147)

  • 1. Modular Vaccine Design Using Carrier-Free Capsules Assembled from Polyionic Immune Signals.
    Chiu YC; Gammon JM; Andorko JI; Tostanoski LH; Jewell CM
    ACS Biomater Sci Eng; 2015 Dec; 1(12):1200-1205. PubMed ID: 26689147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly and Immunological Processing of Polyelectrolyte Multilayers Composed of Antigens and Adjuvants.
    Chiu YC; Gammon JM; Andorko JI; Tostanoski LH; Jewell CM
    ACS Appl Mater Interfaces; 2016 Jul; 8(29):18722-31. PubMed ID: 27380137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response.
    Zhang P; Chiu YC; Tostanoski LH; Jewell CM
    ACS Nano; 2015 Jun; 9(6):6465-77. PubMed ID: 26035231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dose, route, and composition on the immunogenicity of immune polyelectrolyte multilayers delivered on gold templates.
    Zhang P; Andorko JI; Jewell CM
    Biotechnol Bioeng; 2017 Feb; 114(2):423-431. PubMed ID: 27567213
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zeng Q; Gammon JM; Tostanoski LH; Chiu YC; Jewell CM
    ACS Biomater Sci Eng; 2017 Feb; 3(2):195-205. PubMed ID: 28286864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Assembly of Immune Signals to Program Innate Immunity through Rational Adjuvant Design.
    Bookstaver ML; Zeng Q; Oakes RS; Kapnick SM; Saxena V; Edwards C; Venkataraman N; Black SK; Zeng X; Froimchuk E; Gebhardt T; Bromberg JS; Jewell CM
    Adv Sci (Weinh); 2022 Nov; 10(1):e2202393. PubMed ID: 36373708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance.
    Tostanoski LH; Chiu YC; Andorko JI; Guo M; Zeng X; Zhang P; Royal W; Jewell CM
    ACS Nano; 2016 Oct; 10(10):9334-9345. PubMed ID: 27579996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuning innate immune function using microneedles containing multiple classes of toll-like receptor agonists.
    Edwards C; Oakes RS; Jewell CM
    Nanoscale; 2023 May; 15(19):8662-8674. PubMed ID: 37185984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes.
    Powell BS; Andrianov AK; Fusco PC
    Clin Exp Vaccine Res; 2015 Jan; 4(1):23-45. PubMed ID: 25648619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.
    Sánchez-Ramón S; Conejero L; Netea MG; Sancho D; Palomares Ó; Subiza JL
    Front Immunol; 2018; 9():2936. PubMed ID: 30619296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines.
    Savelkoul HF; Ferro VA; Strioga MM; Schijns VE
    Vaccines (Basel); 2015 Mar; 3(1):148-71. PubMed ID: 26344951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Adjuvants and Immunomodulators for Veterinary Vaccines.
    Heegaard PM; Fang Y; Jungersen G
    Methods Mol Biol; 2016; 1349():63-82. PubMed ID: 26458830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH
    Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of Vaccination.
    Zepp F
    Methods Mol Biol; 2016; 1403():57-84. PubMed ID: 27076125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications.
    Tang T; Weng T; Jia H; Luo S; Xu Y; Li L; Zhang P
    Biomater Sci; 2019 Feb; 7(3):715-732. PubMed ID: 30762040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future perspectives for vaccine development.
    Stevens VC
    Scand J Immunol Suppl; 1992; 11():137-43. PubMed ID: 1514029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.
    Russell RF; McDonald JU; Lambert L; Tregoning JS
    J Virol; 2016 May; 90(9):4735-4744. PubMed ID: 26912628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of Heterologous Simian Immunodeficiency Virus SIV
    Singh S; Ramírez-Salazar EG; Doueiri R; Valentin A; Rosati M; Hu X; Keele BF; Shen X; Tomaras GD; Ferrari G; LaBranche C; Montefiori DC; Das J; Alter G; Trinh HV; Hamlin C; Rao M; Dayton F; Bear J; Chowdhury B; Alicea C; Lifson JD; Broderick KE; Sardesai NY; Sivananthan SJ; Fox CB; Reed SG; Venzon DJ; Hirsch VM; Pavlakis GN; Felber BK
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.